Cargando…
Evolving role of high dose stem cell therapy in multiple myeloma
Conventional chemotherapy has been used in the treatment of multiple myeloma. However the development of autologous stem cell transplant represented a major advance in its therapy. Complete response (CR) rates to the tune of 40-45% were seen and this translated into improvements in progression-free...
Autores principales: | Gupta, Ajay, Kumar, Lalit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124984/ https://www.ncbi.nlm.nih.gov/pubmed/21731211 http://dx.doi.org/10.4103/0971-5851.81885 |
Ejemplares similares
-
Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies
por: Larsen, Jeremy T., et al.
Publicado: (2015) -
High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome
por: Kumar, Lalit, et al.
Publicado: (2019) -
Evolving therapeutic role of bisphosphonates in multiple myeloma
por: Ural, A U, et al.
Publicado: (2005) -
The evolving role and utility of off-label drug use in multiple myeloma
por: Stoeckle, James H, et al.
Publicado: (2021) -
High dose therapy and autologous stem cell transplant in older adults with multiple myeloma
por: Wildes, Tanya M, et al.
Publicado: (2015)